BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32682923)

  • 1. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.
    van Lier YF; de Bree GJ; Jonkers RE; Roelofs JJTH; Ten Berge IJM; Rutten CE; Nur E; Kuijpers TW; Hazenberg MD; Zeerleder SS
    Clin Immunol; 2020 Sep; 218():108522. PubMed ID: 32682923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
    Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
    Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Manifestations of GATA2 Deficiency.
    Marciano BE; Olivier KN; Folio LR; Zerbe CS; Hsu AP; Freeman AF; Filie AC; Spinner MA; Sanchez LA; Lovell JP; Parta M; Cuellar-Rodriguez JM; Hickstein DD; Holland SM
    Chest; 2021 Oct; 160(4):1350-1359. PubMed ID: 34089740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA2 and marrow failure.
    Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation.
    Moraes-Fontes MF; Caramalho Í; Hsu AP; Holland SM; Abecasis M
    J Clin Immunol; 2019 Jan; 39(1):4-6. PubMed ID: 30478525
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
    Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
    Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of GATA2 deficiency syndrome.
    Calvo KR; Hickstein DD
    Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rs1573858 GATA-2 homozygote variant associated with pulmonary alveolar proteinosis, cytopenia and neurologic dysfunction.
    China N; Gurioli C; Maitan S; Poletti V
    Pulmonology; 2020; 26(3):178-180. PubMed ID: 31672593
    [No Abstract]   [Full Text] [Related]  

  • 10. Alveolar Proteinosis, Infectious Complications and Monocytopenia Associated with GATA2 Deficiency.
    Raffáč Š; Aljubouri MAS; Gabzdilová J
    Neuro Endocrinol Lett; 2021 Jan; 41(6):290-295. PubMed ID: 33714240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.
    Griese M; Zarbock R; Costabel U; Hildebrandt J; Theegarten D; Albert M; Thiel A; Schams A; Lange J; Krenke K; Wesselak T; Schön C; Kappler M; Blum H; Krebs S; Jung A; Kröner C; Klein C; Campo I; Luisetti M; Bonella F
    BMC Pulm Med; 2015 Aug; 15():87. PubMed ID: 26264606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.
    Tanaka-Kubota M; Shinozaki K; Miyamoto S; Yanagimachi M; Okano T; Mitsuiki N; Ueki M; Yamada M; Imai K; Takagi M; Agematsu K; Kanegane H; Morio T
    Int J Hematol; 2018 May; 107(5):610-614. PubMed ID: 29185156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
    Rajput RV; Arnold DE
    Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Nonmyeloablative Allogeneic Stem Cell Transplant in a Child With Emberger Syndrome and GATA2 Mutation.
    Rastogi N; Abraham RS; Chadha R; Thakkar D; Kohli S; Nivargi S; Prakash Yadav S
    J Pediatr Hematol Oncol; 2018 Aug; 40(6):e383-e388. PubMed ID: 29189513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA2 deficiency.
    Hsu AP; McReynolds LJ; Holland SM
    Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):104-9. PubMed ID: 25397911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
    Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
    Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen.
    Parta M; Shah NN; Baird K; Rafei H; Calvo KR; Hughes T; Cole K; Kenyon M; Schuver BB; Cuellar-Rodriguez J; Zerbe CS; Holland SM; Hickstein DD
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1250-1259. PubMed ID: 29412158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA2 haploinsufficient patients lack innate lymphoid cells that arise after hematopoietic cell transplantation.
    van Lier YF; Krabbendam L; Haverkate NJE; Zeerleder SS; Rutten CE; Blom B; Spits H; Hazenberg MD
    Front Immunol; 2022; 13():1020590. PubMed ID: 36268026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.